A kidney tumour does not automatically mean that the whole kidney needs to be removed.
Treatment depends on what the tumour is, how large it is, where it is located, whether it involves important blood vessels or nearby structures, whether the cancer has spread, and how well the kidneys are functioning.
Depending on the situation, treatment may include:
Cancer control remains the first priority.
When oncologically and technically appropriate, preserving functioning kidney tissue is also an important objective.
The surgical approach — robotic, laparoscopic or open — is selected according to tumour anatomy, disease extent, patient factors and oncological requirements, rather than technology alone.
Dr. Swati H. Shah is a Surgical Oncologist with dedicated uro-oncology training and a focused clinical interest in kidney cancer surgery.
She has been performing robotic surgery since 2013 and has performed more than 100 robotic kidney operations, in addition to her broader experience in robotic uro-gynaecologic cancer surgery.
Her kidney cancer practice includes small renal masses as well as complex, large, recurrent and locally advanced renal tumours, renal-vein/IVC tumour thrombus and selected metastatic disease.
If you have been diagnosed with a kidney tumour or renal mass, the first question is not simply:
“Do I need surgery?”
The important questions are:
A detailed CT or MRI, renal-function assessment and overall clinical evaluation help determine the appropriate treatment pathway.
Surgical Oncologist | Uro-Oncology & Kidney Cancer Surgery
Dr. Swati H. Shah has a focused clinical practice in uro-oncology and pelvic oncology, with experience in kidney cancer surgery across the spectrum of disease.
MS General Surgery — Maulana Azad Medical College, New Delhi | 2008–2011
During her general-surgery training, she had exposure to renal malignancies and renal surgery, including radical nephrectomy, nephrectomy and laparoscopic nephrectomy.
DrNB Surgical Oncology — Rajiv Gandhi Cancer Institute | 2013–2016
Her dedicated surgical-oncology training included extensive exposure to uro-oncology, including renal tumours, large renal tumours, metastatic renal cancer, partial and radical nephrectomy, renal/IVC thrombus, enlarged retroperitoneal lymph nodes, recurrent disease and tumours involving adjacent structures.
She also underwent dedicated uro-oncology training under Dr. Sudhir Rawal.
Her training encompassed open, laparoscopic and robotic approaches.
A renal mass can represent different conditions, including:
The diagnosis and treatment plan depend on imaging characteristics, tumour size and location, clinical factors and, in selected situations, biopsy.
For selected patients, active surveillance may be appropriate.
For others, partial nephrectomy, radical nephrectomy, ablation or other treatment may be considered.
The decision should be individualized rather than based on tumour size alone.
MYTH- Every kidney cancer requires removal of the whole kidney.
FACT- For selected localized tumours, partial nephrectomy can remove the tumour while preserving functioning renal tissue.
MYTH- A small kidney tumour always needs immediate surgery.
FACT- Some small renal masses can be monitored with active surveillance, while others require treatment. The decision depends on the individual tumour and patient.
MYTH- A large kidney tumour automatically means metastatic cancer.
FACT- A tumour can be large while still being confined to the kidney. Size and metastatic spread are different questions.
MYTH- IVC tumour thrombus means kidney cancer cannot be operated.
FACT- Selected patients with renal-vein or IVC tumour thrombus may undergo complex surgery after detailed imaging and multidisciplinary planning.
MYTH- A robot performs the operation by itself.
FACT- Robotic surgery is surgeon-controlled. The robotic platform provides magnified three-dimensional visualization and articulated instruments that may be useful in selected procedures.
Understanding the renal mass is the first step.
Imaging helps determine:
Treatment may involve:
Active surveillance | Partial nephrectomy | Radical nephrectomy | Ablation | Systemic treatment | Selected local treatments
The appropriate option depends on the disease and the patient.
Surgical approaches include:
Robotic | Laparoscopic | Open
There is no single approach that is appropriate for every renal tumour.
Kidney tumours can vary considerably in their behaviour and anatomical complexity.
The surgical spectrum may include:
Partial nephrectomy removes the tumour while preserving the remaining functioning part of the kidney.
Whether it is appropriate depends on:
Radical nephrectomy removes the entire kidney and may be appropriate when partial nephrectomy would not provide a safe or suitable oncological operation.
It may be considered for selected:
Laparoscopic surgery uses small incisions and specialized instruments.
Dr. Shah’s renal surgical experience includes laparoscopic nephrectomy and laparoscopic renal surgery, developed through her surgical-oncology and uro-oncology training and subsequent practice.
Laparoscopy may be appropriate for selected renal tumours, depending on tumour anatomy and surgical requirements.
Dr. Shah began robotic surgery in 2013.
Her robotic experience includes:
Her experience includes robotic kidney-sparing surgery as well as robotic nephrectomy and selected complex renal procedures.
The robotic platform can provide:
However, the robot is a surgical tool. Patient selection and surgical expertise remain more important than technology alone.
Approach | Possible advantages | When it may be considered |
Robotic | 3D magnification, articulated instruments, precise suturing | Selected partial and radical nephrectomy and appropriately selected complex tumours |
Laparoscopic | Minimally invasive approach with small incisions | Selected renal tumours suitable for laparoscopic surgery |
Open | Direct access and flexibility for extensive disease | Selected large, locally advanced, recurrent or highly complex tumours |
The safest oncological approach is selected according to the tumour and the patient.
Dr. Shah underwent dedicated uro-oncology training under Dr. Sudhir Rawal during her surgical-oncology training.
Her clinical experience includes:
Her overall robotic oncology experience is approximately 650 robotic uro- and gynaecologic cancer surgeries, while the kidney-specific experience is described separately as more than 100 robotic kidney operations.
Some renal tumours are technically challenging because of their:
These cases may require detailed imaging, careful operative planning and multidisciplinary involvement.
Kidney cancer can sometimes extend into the renal vein or inferior vena cava.
Dr. Shah’s experience includes:
Very extensive tumour thrombus extending toward the heart requires highly specialized planning and appropriate multidisciplinary support.
Kidney cancer may sometimes extend beyond the kidney, involve nearby structures, lymph nodes, major veins or distant organs.
Management may require:
Surgery is not appropriate for every patient with metastatic kidney cancer.
In selected patients, however, surgery may form part of an individualized treatment strategy, often alongside systemic treatment and multidisciplinary decision-making.
MS General Surgery from Maulana Azad Medical College followed by DrNB Surgical Oncology at Rajiv Gandhi Cancer Institute, with dedicated uro-oncology training under Dr. Sudhir Rawal.
Robotic surgery experience dating back to 2013, with more than 100 robotic kidney operations.
Experience extending from small renal masses and nephron-sparing surgery to large, recurrent, locally advanced and complex renal tumours.
Experience includes renal-vein and IVC tumour thrombus, major-vessel relationships, advanced renal tumours and selected adjacent-organ resections.
Complex cases may require coordinated planning involving surgical oncology, uro-oncology, radiology, pathology, vascular surgery, gastrointestinal surgery, anaesthesia and medical oncology, depending on the disease.
The surgical approach is selected according to cancer control, tumour anatomy, kidney preservation, patient factors and long-term outcomes.
Dr. Shah’s kidney cancer experience also includes academic teaching and professional presentations.
Faculty participation at an IASO conference in Kolkata in 2019, including discussion related to small renal masses.
Conducted a training workshop for urologists on robotic kidney surgery.
Presented kidney cancer surgery videos through professional surgical meetings and academic platforms in Gujarat, Rajasthan, Madhya Pradesh and elsewhere.
Presented work related to robotic uro-oncology.
Conducted academic webinars and sessions demonstrating robotic partial nephrectomy, laparoscopic renal surgery and radical nephrectomy.
Dr. Shah initiated PROM, a multidisciplinary academic forum bringing together radiologists and oncologists for discussion of radiological assessment and oncological management.
For renal tumours, imaging interpretation is particularly important for understanding:
Dr. Shah also initiated POINT, a multidisciplinary academic forum involving pathologists and oncologists, with discussion of tumour pathology, biology, immunology and novel therapeutic approaches.
These initiatives reflect an emphasis on multidisciplinary cancer decision-making rather than surgery in isolation.
“Technique and Intraoperative Strategy for Circumferential Resection of Perirenal Inferior Vena Cava with Bilateral Renal Vein Reconstruction”
Published in the Indian Journal of Vascular and Endovascular Surgery in 2025.
The reported case involved a retroperitoneal dedifferentiated liposarcoma involving the perirenal IVC and both renal veins, requiring complex vascular resection and bilateral renal-vein reconstruction.
This publication demonstrates experience in:
It is not a publication about renal cell carcinoma or RCC tumour thrombus.
Clinical experience is supported by a dedicated case library and surgical video collection.
Cases include examples of:
Kidney Cancer Case Library: https://drswatishah.in/case-library-kidney-cancer/
Short videos demonstrate selected aspects of kidney tumour and kidney cancer surgery, including evaluation, tumour anatomy, kidney preservation, radical surgery and complex renal cancer surgery.
Patient reviews and testimonials can help patients understand the experience of undergoing cancer treatment.
This video features a patient’s family member sharing their experience regarding a successful major cancer surgery performed by Dr. Swati Shah. The patient was diagnosed with a tumor in the left kidney that had extended into the main blood vessel (IVC), requiring emergency intervention. Dr. Swati Shah expertly managed the complex radical nephrectomy with thrombus removal, successfully completing the major operation with no complications. Following a one-week hospital stay and excellent follow-up care, the patient returned for a successful 15-day post-operative review. The family expressed deep gratitude and complete satisfaction with Dr. Shah’s exceptional surgical care and compassionate approach.
This video features a patient sharing a successful recovery story following a complex kidney cancer surgery performed by Dr. Swati and Dr. Harsh Shah at Uro-Gynec & GI Cancer Surgery. The patient was diagnosed with a challenging renal mass accompanied by an Inferior Vena Cava (IVC) thrombus. Despite having consulted multiple other medical facilities and reviewing reports elsewhere, the patient experienced an exceptionally positive outcome from the radical nephrectomy and IVC thrombus removal procedure. Expressing deep satisfaction with the surgical care received, the patient strongly recommends others facing similar health diagnoses to consult Dr. Swati Shah for reliable and effective medical treatment.
In the video, a patient who traveled from Indore, shares her immensely positive experience regarding a complex medical procedure. She was diagnosed with kidney cancer involving an IVC thrombus, and she underwent a radical nephrectomy with IVC thrombus resection performed by Dr. Shah. The patient’s family explains that they discovered Dr. Swati Shah through a Google search and were deeply impressed by her outstanding reviews and reputation. During their consultation, Dr. Shah’s reassuring approach gave them the necessary confidence to proceed with the critical operation. The patient expresses profound gratitude, highlighting that the surgical process was incredibly smooth, straightforward, and highly successful.
Short videos and anonymised case summaries from Dr Swati Shah’s kidney cancer practice, shared for patient education.
Kidney tumour: save the kidney or remove it? How size, location and kidney function guide the choice.
Partial vs radical nephrectomy. When kidney preservation is possible for a renal mass.
Partial nephrectomy in kidney cancer. What nephron-sparing surgery aims to do.
A 71-year-old woman had a renal mass in the superior pole of the left kidney; robotic partial nephrectomy aimed to remove the lesion while preserving healthy renal tissue.
A 59-year-old man had a necrotic left renal mass invading the renal sinus with a metastasis in the right adrenal gland, managed with robotic radical nephrectomy and right adrenalectomy.
Why the choice differs. A small, localised renal cell carcinoma may suit nephron-sparing surgery, while a tumour invading the renal sinus or with adrenal metastasis may need radical nephrectomy. Imaging, histology and renal function guide the decision.
Anonymised summaries for patient education. Every patient’s plan is individual, and a past case does not predict an individual result.
Robotic surgery does not mean that a robot independently performs the operation.
The surgeon controls the robotic system throughout the procedure.
The technology can provide:
But technology alone does not determine the outcome.
The appropriate operation, correct patient selection and surgical expertise remain fundamental.
Kidney cancer treatment is based on established oncological principles and contemporary evidence.
Treatment decisions should consider:
Guidelines and evidence provide a framework, but treatment still needs to be individualized.
Dr. Shah’s robotic experience began in 2013.
Her academic work includes:
Her experience includes both performing robotic surgery and sharing surgical knowledge through professional academic platforms.
Robotic surgery may be useful for selected:
However, robotic surgery is not automatically appropriate for every kidney tumour.
Large, recurrent or locally advanced tumours may require laparoscopic or open surgery depending on anatomy and oncological requirements.
The operation should be chosen for the patient — not the technology.
No. Selected small renal masses may be monitored, while others require treatment.
In selected tumours, partial nephrectomy may preserve functioning kidney tissue.
No. Tumour anatomy and oncological considerations determine suitability.
Central or hilar location, endophytic growth, proximity to vessels or collecting system, multifocal disease, solitary kidney and previous surgery can increase complexity.
Not automatically. The size, location, extent and feasibility of kidney preservation need to be assessed.
Yes. Some kidney cancers develop renal-vein or IVC tumour thrombus and may require complex surgery.
In selected patients, surgery may have a role as part of an individualized multidisciplinary treatment strategy.
Yes, in appropriately selected patients.
Follow-up includes review of pathology, renal function, recurrence risk and individualized surveillance.
A second opinion may be useful when:
Bring your:
The aim of a second opinion is not simply to choose robotic versus open surgery.
It is to understand the disease, the available options and the safest oncological strategy for your individual situation.
Does it need treatment?
Can the kidney be preserved?
What does kidney-sparing robotic surgery involve?
How can outcomes be optimized?
How does management change with size and local extent?
When can surgery have a role?
What if the tumour has grown into the vein?
When does the whole kidney need to be removed?
What happens after treatment?
Dr. Swati H. Shah practices in Ahmedabad and receives patients from Gujarat and neighbouring states, including Madhya Pradesh and Rajasthan, as well as selected international patients.
The aim is to provide specialized kidney cancer and uro-oncology care while helping patients understand their diagnosis, treatment choices and surgical options.
You do not need to decide about surgery based on tumour size alone.
The right treatment depends on:
The tumour + the kidney + the stage + your overall health + the safest oncological approach.
If you have a kidney tumour, renal mass, kidney cancer, renal-vein/IVC thrombus or a complex renal tumour, a specialist uro-oncology assessment can help clarify your treatment options.
Book a Consultation / Seek a Second Opinion
Dr. Swati H. Shah is a Surgical Oncologist with dedicated uro-oncology training and robotic experience since 2013, managing kidney tumours across the spectrum from small renal masses and nephron-sparing surgery to large, recurrent and locally advanced renal tumours, renal-vein/IVC thrombus and selected metastatic disease, using robotic, laparoscopic or open surgery according to tumour anatomy and oncological requirements.
Her approach is based on:
Cancer control + kidney preservation + appropriate surgical approach + multidisciplinary care.
The information on this page is for general educational purposes and does not replace individualized medical consultation. The appropriate treatment for a kidney tumour depends on the patient’s clinical condition, imaging, tumour characteristics, renal function, stage and other relevant factors.
Swasth Parivar: every week, practical advice on recovery, diet and warning signs. No advertising. Stop any time.
Your number is used for these updates and for the clinic to reach you. It is never sold or passed on. To stop, reply STOP on WhatsApp.
